What are the updates in the 2026 American Society for Parenteral and Enteral Nutrition (ASPEN) ICU nutrition guidelines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

There Are No 2026 ESPEN/ASPEN ICU Nutrition Guidelines

Based on the available evidence, there are no published 2026 ESPEN or ASPEN ICU nutrition guidelines. The most recent ESPEN guideline on clinical nutrition in the ICU was published in 2019 1, with a 2023 implementation position paper from the ESPEN Special Interest Group 2. The research articles from 2026 3, 4, 5 are not official guidelines but rather reviews and practical adaptations of existing recommendations.

Current State of ICU Nutrition Guidelines (2019 ESPEN + 2023 Implementation Updates)

Grade A Recommendations (Must Implement)

Feeding Route and Timing

  • Early enteral nutrition (EN) within 48 hours shall be initiated over early parenteral nutrition (PN) when oral intake is not possible 2
  • Avoid early full EN or PN to prevent overfeeding; prescribe within 3-7 days to reach targets 2
  • Progress EN gradually to reach energy targets by day 4-6, depending on tolerance 2

Glutamine Contraindications

  • Parenteral glutamine dipeptide shall NOT be administered in unstable/complex ICU patients, particularly those with liver failure, renal failure, or multi-organ failure 2
    • Exception: Consider enteral glutamine (0.3-0.5 g/kg/day for 10-15 days) in burn patients >20% body surface area 2

Glucose Control

  • Insulin shall be administered when glucose levels exceed 10 mmol/L (180 mg/dL) 2
  • Target glucose rapidly and avoid variability outside target range 2
  • Consider decreasing carbohydrate load and using fat-enriched formulas if hyperglycemia persists 2

Grade B Recommendations (Strongly Advised)

Supplemental Parenteral Nutrition (SPN)

  • If EN is insufficient or not tolerated by day 4, initiate PN or SPN within 3-7 days 2
  • Start PN by day 3 at earliest to prevent overfeeding complications, which peak during first 3 days of critical illness 2
  • Both undernutrition and overnutrition are harmful; individualize timing based on nutritional status and GI tolerance 2

When to Delay EN (ESICM-endorsed)

EN should be delayed or given at low doses when 2:

  • Shock is uncontrolled and hemodynamic/perfusion goals not reached (start low-dose EN once shock controlled with fluids/vasopressors)
  • Uncontrolled life-threatening hypoxemia, hypercapnia, or acidosis
  • Active upper GI bleeding (restart when bleeding controlled)

Trauma Patients

  • Trauma patients should preferentially receive early EN instead of early PN 2

Micronutrients with PN

  • Trace elements and vitamins must be provided daily with PN to enable substrate metabolism 2
  • High-dose antioxidant monotherapy should not be given without proven deficiency 2

Refeeding Syndrome

  • In patients with refeeding hypophosphatemia, restrict energy supply for 48 hours, then gradually increase 2
  • Measure potassium, phosphorus, and magnesium before and within 6 hours of starting nutrition support 2

Emerging Concepts from 2026 Research (Not Official Guidelines)

The 2026 literature 3, 5 suggests evolving perspectives:

Phase-Based Nutrition Approach

  • Early acute phase (first week): Limit energy to 70-80% of full nutrition due to endogenous glucose production; protein ≤1.2 g/kg/day 3
  • Late acute phase (after week 1): Increase to 100% energy targets and protein 1.2-2.0 g/kg/day 3
  • Chronic/convalescent phase: May require even higher energy and protein to regain muscle mass 3

Parenteral Nutrition Reconsideration

  • Historical negative outcomes with PN likely driven by overfeeding rather than route itself 5
  • With conservative energy delivery and strict aseptic technique, TPN/SPN may be as safe as EN 5
  • Consider SPN post-ICU when oral intake insufficient to support rehabilitation 5

Key Contraindications and Pitfalls

Avoid:

  • IV glutamine in organ failure (liver, renal, multi-organ) 2
  • High-dose omega-3 enriched EN by bolus administration 2
  • Routine use of high-dose omega-3 enriched enteral formulas 2
  • Early full feeding (100% energy target before day 4) in acute phase 2

Common Implementation Gaps 2:

  • Micronutrients frequently omitted from PN prescriptions
  • Lack of specific protocols for trauma, obese, or surgical patients
  • Insufficient monitoring of phosphate in refeeding risk patients
  • Delayed recognition of EN intolerance requiring SPN

Practical Algorithm

  1. Day 0-2: Start trophic EN within 48 hours if no contraindications
  2. Day 3-4: Assess EN tolerance; if <60% target, plan SPN by day 3-7
  3. Day 4-6: Progress to energy targets (70-80% early phase, then 100%)
  4. Throughout: Monitor glucose (treat >10 mmol/L), electrolytes (refeeding), GI tolerance
  5. Post-ICU: Reassess for higher energy/protein needs during rehabilitation

The 2019 ESPEN guidelines 1 remain the current standard, with the 2023 implementation paper 2 providing practical guidance for adoption.

References

Related Questions

What is the recommended strategy for amino‑acid‑enriched enteral nutrition versus total parenteral nutrition (TPN) in critically ill and perioperative patients, including protein and caloric targets and indications for each route?
What are the bedside decision‑making considerations for enteral and parenteral nutrition, including feeding during vasopressor therapy, choice of gastric versus post‑pyloric feeding, and indications for supplemental parenteral nutrition?
In a patient with recent clot formation requiring mesh placement, ongoing internal bleeding, and who has been NPO for more than one week, is initiation of total parenteral nutrition appropriate?
What is the protein‑versus‑energy shifting concept for nutrition in critically ill or malnourished patients, including recommended protein (1.2–2.0 g/kg/day) and calorie (20–25 kcal/kg/day) targets?
In a dehydrated patient with persistent vomiting who cannot tolerate oral intake, how should total parenteral nutrition be initiated, including dextrose, amino‑acid, electrolyte, thiamine, and lipid dosing and monitoring?
In a patient with acute alcoholic hepatitis and thrombocytopenia, should I order hepatitis A virus (HAV) IgM and hepatitis E virus (HEV) IgM serologies?
What prednisolone dosage is recommended for treating lichen planus?
What pharmacologic options can be used to reduce transfusion requirements in a patient with severe cytopenias, targeting a platelet count >50 ×10⁹/L and white‑blood‑cell count >3 ×10⁹/L?
What is the recommended prednisolone dosage for an adult with newly diagnosed pemphigus vulgaris?
In a patient already on dual antiplatelet therapy, should a loading dose be administered when they present with ST-elevation myocardial infarction (STEMI)?
In a patient with a rising alanine aminotransferase (ALT) level, which medication is safer to prescribe, pregabalin or gabapentin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.